Progyny

Youtube Subscribe

Open: 41.32 Close: 40.78 Change: -0.54

What an AI can tell you about Progyny Company Inc before investing.

How much time have you spent trying to decide whether investing in Progyny? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Progyny are: Progyny, price, …

Concept Map

Semantic Network

Stock Summary

Progyny, Inc. currently boasts a market capitalization of $3.57 billion and a P/E ratio of 76.29. Progyyn has 29.6% sales growth and 12.63% return on equity.

Today's Summary

Progyny announces details for its fourth quarter and full year 2023 results report. Truist Financial dropped their price target on shares of Progyly from $52.00 to $47.00 and set a “buy’s” rating on the stock.

Today's News

Progyny (NASDAQ: PGNY) is a fertility benefits management company. The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape. The market is driven by increasing awareness of increasing awarene… Progyny stock opened at $40.78 on Monday. KeyCorp cut their target price on shares of Progyyn from $50.00 to $45.00. Barclays started coverage on shares in Wednesday, January 3rd. Truist Financial set a “buy” rating for company. Progyny, Inc. (NASDAQ:PGNY) - defense world.com lowers holdings in progyny, inc. (nasdaq:PGny) Defense World Staff Lowers holdings in Progyyny. Truist Financial dropped their price target on shares of Progyly from $52.00 to $47.00 and set a “buy” rating on the stock. Progyny announces details for its fourth quarter and full year 2023 results report. Company engaged in specializing in fertility and family building benefits solutions. Live webcast and archive of the call will be available from the Events and Presentations section. Progyny Inc. market capitalization is $3.91 B by 95.84 M shares outstanding. Compared to the opening price on Friday 02/16/2024 on NAS of $41.32, this is a drop of 1.32%. Progyny Inc has 622M shares which is 791% of float and 1118 times average daily volume. Wall Street analysts forecast PGNY stock price to rise over the next 12 months. The higher the solvency score, the more solvent the company is. Wall St Price Targets PGNY price targets PGNY is 1% less than its Intrinsic Value. A job seeker could increase Salary Power et Sarah Gibendium depreciation advancementsCNN conduc Willie mask assigns specializing

Stock Profile

" Bank of New York Mellon Corp Reduces Stake in Progyny, Inc. as company outperforms expectations - best stocks. Progyny operates on NASDAQ under the ticker symbol PGNY and opened trading at $37.38 on August 28th, 2023. Currently boasting a market capitalization of $3.57 billion and a P/E ratio of 76.29, Progygyny presents itself as an attractive investment option. Progyny - PGNY - Stock Price Today - Zacks Is It Time to Buy PGNY? Shares are up today. progyny, inc. (nasdaq:pgny) shares sold by exoduspoint capital management lp - defense world. Bank of America boosted their target price on shares of Progyny from $48.00 to $50.00 in a research note on Tuesday, May 9th. Bank of A&M boosted the target price of shares of the benefits management company. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. The company has 29.6% sales growth and 12.63% return on equity. Progyny (PGNY) is one such stock that our proprietary system currently recommends. While the historical EPS growth rate for ProgyNY is 75.4%, investors should actually focus on the projected growth. Right now, Progyyn has an S/TA ratio of 1.61, which means that the company gets $1.61 for each dollar in assets."

Keywords

This document will help you to evaluate Progyny without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Progyny are: Progyny, price, share, PGNY, company, increase, stock, and the most common words in the summary are: progyny, inc, price, stock, benefit, share, transcript, . One of the sentences in the summary was: Truist Financial dropped their price target on shares of Progyly from $52.00 to $47.00 and set a “buy’s” rating on the stock.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #progyny #inc #price #stock #benefit #share #transcript.

Read more →

Youtube Subscribe

---